Literature DB >> 8634698

Murine Brca1: sequence and significance for human missense mutations.

S K Sharan1, M Wims, A Bradley.   

Abstract

We have cloned and sequenced a mouse homologue of the human breast and ovarian cancer susceptibility gene, BRCA1. The predicted mouse Brca1 protein is composed of 1812 amino acids. The murine protein is 60% identical and 72% similar to the human BRCA1 protein. Two regions of high homology have been identified between the two proteins. First is the Cys3-His-Cys4 type zinc-finger domain that is identical between the two proteins. The second region is defined by 115 amino acids near the carboxyl end of the Brca1 protein that is 83% identical to human BRCA1 sequence. Seven of eight amino acids involved in human missense mutations that are associated with the disease were found to be conserved between the two species. In contrast, most of the amino acids that are involved in polymorphic variations were not conserved. We therefore propose that the interspecies conservation of predicted amino acid sequences can be used as an additional criterion to determine the significance of human missense mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8634698     DOI: 10.1093/hmg/4.12.2275

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  10 in total

Review 1.  Expression of BRCA1 and BRCA2 in normal and neoplastic cells.

Authors:  L A Chodosh
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

2.  Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

Authors:  Y Jin; X L Xu; M C Yang; F Wei; T C Ayi; A M Bowcock; R Baer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

Authors:  S A Gayther; P Harrington; P Russell; G Kharkevich; R F Garkavtseva; B A Ponder
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Classification of BRCA1 missense variants of unknown clinical significance.

Authors:  C M Phelan; V Dapic; B Tice; R Favis; E Kwan; F Barany; S Manoukian; P Radice; R B van der Luijt; B P M van Nesselrooij; G Chenevix-Trench; T Caldes; M de la Hoya; S Lindquist; S V Tavtigian; D Goldgar; A Borg; S A Narod; A N A Monteiro
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

Review 5.  Functional characterization of BRCA1 and BRCA2: clues from their interacting proteins.

Authors:  S K Sharan; A Bradley
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

6.  Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function.

Authors:  Victoria E Mgbemena; Robert A J Signer; Ranjula Wijayatunge; Travis Laxson; Sean J Morrison; Theodora S Ross
Journal:  Cell Rep       Date:  2017-01-24       Impact factor: 9.423

7.  Localization of BRCA1 and a splice variant identifies the nuclear localization signal.

Authors:  S Thakur; H B Zhang; Y Peng; H Le; B Carroll; T Ward; J Yao; L M Farid; F J Couch; R B Wilson; B L Weber
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

8.  Evidence for a transcriptional activation function of BRCA1 C-terminal region.

Authors:  A N Monteiro; A August; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

9.  BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks.

Authors:  Ulrica K Westermark; Marsha Reyngold; Adam B Olshen; Richard Baer; Maria Jasin; Mary Ellen Moynahan
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

10.  The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives.

Authors:  J H Sng; J Chang; F Feroze; N Rahman; W Tan; S Lim; M Lehnert; S van der Pool; J Wong
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.